October 2, 2024
BARCELONA — The oncologist’s goal is to provide cancer patients with the most effective and least toxic treatment available. For patients with brain metastases, whole-brain radiotherapy […]
October 2, 2024
WASHINGTON, DC — Radiation oncologists can feel confident offering hypofractionated treatment regimens to treat breast cancer in patients who are planning breast reconstruction after mastectomy, following […]
October 1, 2024
The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson’s ustekinumab (Stelara). This is the fourth ustekinumab biosimilar approved […]
October 1, 2024
Adequate lymph node yield for patients with papillary thyroid cancer is associated with longer operations, longer hospitalization, and higher risk of recurrent laryngeal nerve injury and […]
October 1, 2024
Among patients with Crohn’s disease, a multicenter prospective cohort study found that anti-TNF therapy failed to achieve remission at 3 years in about two-thirds of cases, […]
October 1, 2024
PHILADELPHIA — The investigational agent ecopipam reduces tic severity in children and adolescents with Tourette syndrome (TS) without exacerbating common psychiatric comorbidities, results of a new […]
October 1, 2024
MADRID — Metformin is taken every day by more than 200 million people worldwide. Its value as a glucose-lowering agent has been established for decades. But […]
October 1, 2024
When Russia occupied and annexed Crimea in 2014, Ukraine’s neurosurgeons saw a grim preview of the full-scale war that was yet to come. “We lost not […]
October 1, 2024
MADRID — Individuals with type 2 diabetes and/or obesity plus one or more metabolic risk factors are at a higher risk for metabolic dysfunction–associated steatotic liver […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482
Next page